J. David Sakura

Director/Board Member at

Vectorlogics, Inc.

Finance

Consumer Services

Health Technology

Profile

In addition to his role with Integra Ventures, Dr. Sakura is an advisor with Fortis Bank Biotechnology.
He has several years of Life Science investing experience.

J. David Sakura active positions

Companies	Position	Start
Integra Ventures Integra Ventures Investment ManagersFinance Integra Ventures seeks investment opportunities companies located in the United States. The firm targets companies operating in the fields of drug development, biotech, medical devices and healthcare services. It provides financing for seed, early, late, growth and recapitalizations with an investment size ranging from $500,000 to $3 million. It acts as both lead and co-investor.	Private Equity Investor	2010-12-09
Vectorlogics, Inc. Vectorlogics, Inc. BiotechnologyHealth Technology Develops and commercialized vaccines for virus based cancer therapies and viral liver diseases	Director/Board Member	2009-12-13

All active positions of J. David Sakura

Training of J. David Sakura

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of J. David Sakura's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Integra Ventures Integra Ventures Investment ManagersFinance Integra Ventures seeks investment opportunities companies located in the United States. The firm targets companies operating in the fields of drug development, biotech, medical devices and healthcare services. It provides financing for seed, early, late, growth and recapitalizations with an investment size ranging from $500,000 to $3 million. It acts as both lead and co-investor.	Finance
University of Arizona University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vectorlogics, Inc. Vectorlogics, Inc. BiotechnologyHealth Technology Develops and commercialized vaccines for virus based cancer therapies and viral liver diseases	Health Technology